Auricular points acupressure for insulin resistance in overweight/obese women with polycystic ovary syndrome: protocol for a randomised controlled pilot trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 05 2019
Historique:
entrez: 31 5 2019
pubmed: 31 5 2019
medline: 2 6 2020
Statut: epublish

Résumé

Approximately 5%-20% of reproductive women suffer from polycystic ovary syndrome (PCOS). Auricular points acupressure (AA) may serve as alternative management for PCOS for its benefits in both physical and psychological well-being. However, the effects of AA for insulin resistance (IR) in overweight/obese PCOS women have not been confirmed. The present study is designed as a randomised, placebo-controlled pilot trial to evaluate the effectiveness and safety of AA in treating IR in women with PCOS. A total of 60 eligible PCOS subjects will be randomised into an intervention group (AA group) and a control group (sham AA group) in a ratio of 1:1. Magnetic beads will be taped to the auricular points by the same senior acupuncture specialist from the First Affiliated Hospital, Heilongjiang University of Chinese Medicine. The treatment will last for 12 weeks. Primary outcome measure will be changes in homeostasis model assessment of IR between baseline and after 3 months of AA/sham AA treatment. Secondary outcomes include hormonal profile, weight, waist/hip circumference, body mass index, blood pressure, Ferriman-Gallwey score, acne and the assessment of health-related quality of life. Outcome measures are collected at baseline and the end of treatment visit. The protocol has been approved by the ethics committee of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine (HZYLLKY201800301). Written informed consent will be obtained from all participants. The results will be disseminated through peer-reviewed journals for publications. NCT03546595; Pre-results.

Identifiants

pubmed: 31142530
pii: bmjopen-2018-027498
doi: 10.1136/bmjopen-2018-027498
pmc: PMC6549699
doi:

Banques de données

ClinicalTrials.gov
['NCT03546595']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e027498

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Curr Med Sci. 2018 Dec;38(6):1109-1116
pubmed: 30536077
J Altern Complement Med. 2008 Apr;14(3):303-7
pubmed: 18399759
Health Qual Life Outcomes. 2005 Apr 16;3:26
pubmed: 15833138
Fertil Steril. 2011 Sep;96(3):792-6
pubmed: 21762890
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Complement Ther Med. 2014 Apr;22(2):266-77
pubmed: 24731898
Noro Psikiyatr Ars. 2014 Dec;51(4):328-333
pubmed: 28360650
PLoS One. 2014 May 21;9(5):e97553
pubmed: 24849077
Patient Prefer Adherence. 2017 Mar 02;11:423-429
pubmed: 28280314
Trends Mol Med. 2006 Jul;12(7):324-32
pubmed: 16769248
Zhongguo Zhen Jiu. 2014 Apr;34(4):355-8
pubmed: 24946636
Reprod Biomed Online. 2016 Jan;32(1):44-53
pubmed: 26656973
Fertil Steril. 2017 Mar;107(3):796-802
pubmed: 28104244
Zhongguo Zhen Jiu. 2017 Nov 12;37(11):1163-8
pubmed: 29354951
Fertil Steril. 2004 Oct;82(4):893-902
pubmed: 15482765
Hum Reprod Update. 2012 Nov-Dec;18(6):638-51
pubmed: 22824735
Nat Rev Dis Primers. 2016 Aug 11;2:16057
pubmed: 27510637
Qual Life Res. 2016 Jul;25(7):1791-801
pubmed: 26814480
N Engl J Med. 2004 Sep 9;351(11):1106-18
pubmed: 15356308
J Clin Endocrinol Metab. 2005 Mar;90(3):1360-5
pubmed: 15598674
Trials. 2017 Mar 9;18(1):115
pubmed: 28274268
Obes Res. 1995 Dec;3 Suppl 5:667S-673S
pubmed: 8653547
Fertil Steril. 2011 Aug;96(2):452-8
pubmed: 21703610
Evid Based Complement Alternat Med. 2014;2014:343608
pubmed: 25574180
J Womens Health (Larchmt). 2009 Jun;18(6):813-8
pubmed: 19445642
Folia Histochem Cytobiol. 2007;45 Suppl 1:S93-7
pubmed: 18292843
J Altern Complement Med. 2013 Sep;19(9):740-5
pubmed: 23676106
Hum Reprod. 2006 Aug;21(8):2027-32
pubmed: 16684838
BMJ Open. 2019 Jan 4;9(1):e024733
pubmed: 30612112
Stat Methods Med Res. 2016 Jun;25(3):1057-73
pubmed: 26092476
Int J Reprod Biomed (Yazd). 2017 Jul;15(7):423-428
pubmed: 29177243
Am J Med. 2003 Mar;114(4):299-306
pubmed: 12681458

Auteurs

Yan Li (Y)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Lihui Hou (L)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Yingji Wang (Y)

School of Pharmacy, Harbin Medical University, Harbin, China.

Liangzhen Xie (L)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Meiwei Zhang (M)

Heilongjiang University of Chinese Medicine, Harbin, China.

Zimeng Pan (Z)

Heilongjiang University of Chinese Medicine, Harbin, China.

Yangyang Li (Y)

Heilongjiang University of Chinese Medicine, Harbin, China.

Yicheng Ding (Y)

Heilongjiang University of Chinese Medicine, Harbin, China.

Miao Sun (M)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Yufang Qu (Y)

Qiqihar Traditional Chinese Medicine Hospital, Qiqihar, China.

Songjiang Liu (S)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH